"A once-weekly tirzepatide versus insulin glargine on glycemic control and cardiovascular outcomes in patients with type 2 diabetes." Diabetes Care , 44(7), 15791587
Pens also eliminate needle-drawing anxiety for people with needle phobia, though they still involve skin penetration
This dose can be increased by 2.5 mg every four weeks for additional diabetes control or to achieve weight loss goals up to a maximum dose of 15 mg once a week
We plan to expand GLP-1s are the first use case, but additional drug categories will follow as manufacturer partnerships grow
Semaglutide injections, along with a healthy diet, exercise, and lifestyle changes, are the key to creating a realistic, attainable weight loss and maintenance program